Apimeds Pharmaceuticals Ownership & Insider Activity

Apimeds Pharmaceuticals (APUS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 11.1% of shares outstanding. Institutional investors hold 0.4%.

Shares Outstanding

1.509M

Shares Float

805.943K

Insider Shares Owned

1.671M

Insider % Owned

11.1%

Institutional Shares Held

6.628K

Institutional % Held

0.4%

Ownership Breakdown

Net Insider Activity by Month

Apimeds Pharmaceuticals Insider Transactions (Last 6 Months)

No insider filings in the last 6 months.